Literature DB >> 27755057

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Biased-Coin Up-and-Down Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 10 mL of Bupivacaine 0.0625% With Fentanyl 2 μg/mL.

Marcelo Epsztein Kanczuk1, Nicholas Martin Barrett, Cristian Arzola, Kristi Downey, Xiang Y Ye, Jose C A Carvalho.   

Abstract

BACKGROUND: Most studies that have compared programmed intermittent epidural bolus (PIEB) with continuous epidural infusion regimens have included patient-controlled epidural analgesia and/or manual bolus as rescue analgesia for breakthrough pain. Consequently, the optimal time interval between PIEB is yet to be determined. We designed a study to establish the optimal time interval between PIEB of 10 mL of bupivacaine 0.0625% with fentanyl 2 μg/mL to produce effective analgesia in 90% of women during first stage of labor without breakthrough pain.
METHODS: We conducted a double-blind sequential allocation trial with a biased-coin up-down design to obtain the effective interval 90% for the PIEB regimen. We included American Society of Anesthesiologists physical status 2-3 nulliparous women at term undergoing spontaneous or induced labor requesting epidural analgesia. An ultrasound-assisted epidural catheter placement was performed at L2/3 or L3/4. A test dose of 3 mL of bupivacaine 0.125% plus fentanyl 3.3 μg/mL was followed by a loading dose of 12 mL of the same solution. PIEB was then started in women whose pain scores achieved Verbal Numerical Rating Score ≤1/10 within 20 minutes after the end of the loading dose. In all subjects, the programmed bolus dose was fixed at 10 mL of bupivacaine 0.0625% with fentanyl 2 μg/mL. The first bolus was delivered 1 hour after the loading dose. The PIEB interval was set at 60 minutes for the first patient and at varying time intervals (60, 50, 40, and 30 minutes; groups 60, 50, 40 and 30, respectively) for the subsequent patients, according to a biased-coin design. The primary outcome was effective analgesia, defined as no requirement for a patient-controlled epidural analgesia or a manual bolus for 6 hours after the initiation of the epidural analgesia or until the patient presented with full cervical dilatation, whichever event occurred first. Pain scores, sensory block levels to ice, degree of motor block, and blood pressure were assessed hourly.
RESULTS: We studied 40 women. The estimated effective interval 90% was 42.6 minutes (95% confidence interval 38.9-46.4) using the truncated Dixon and Mood method and 36.8 minutes (95% confidence interval 31.0-49.0) using the Isotonic Regression analysis. Almost 70% of the patients in group 30 presented with sensory block above T6, compared with 44%, 22%, and 11% in groups 40, 50, and 60, respectively. Only patients in group 30 presented with motor blockade. The incidence of hypotension was low in all groups with no treatment required. DISCUSSION: The optimal time interval between PIEB of 10 mL of bupivacaine 0.0625% with fentanyl 2 μg/mL is approximately 40 minutes. Further studies to determine the efficacy of this regimen throughout the entire duration of labor are warranted.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27755057     DOI: 10.1213/ANE.0000000000001655

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  Patient intermittent epidural boluses (PIEB) plus very low continuous epidural infusion (CEI) versus patient-controlled epidural analgesia (PCEA) plus continuous epidural infusion (CEI) in primiparous labour: a randomized trial.

Authors:  Maria Belen Rodríguez-Campoó; Antonio Curto; Manuel González; Cesar Aldecoa
Journal:  J Clin Monit Comput       Date:  2018-11-30       Impact factor: 2.502

Review 2.  Modern Neuraxial Anesthesia for Labor and Delivery.

Authors:  Marie-Louise Meng; Richard Smiley
Journal:  F1000Res       Date:  2017-07-25

3.  Programmed intermittent epidural bolus as compared to continuous epidural infusion for the maintenance of labor analgesia: a prospective randomized single-blinded controlled trial.

Authors:  Christina W Fidkowski; Sonalee Shah; Mohamed-Rida Alsaden
Journal:  Korean J Anesthesiol       Date:  2019-06-20

4.  A comparison of maternal fear of childbirth, labor pain intensity and intrapartum analgesic consumption between primiparas and multiparas: A cross-sectional study.

Authors:  Yongfang Deng; Yan Lin; Liyuan Yang; Qiuxia Liang; Bailing Fu; Huixian Li; Huizhu Zhang; Yan Liu
Journal:  Int J Nurs Sci       Date:  2021-09-16

5.  Optimization of programmed intermittent epidural bolus volume for different concentrations of ropivacaine in labor analgesia: a biased coin up-and-down sequential allocation trial.

Authors:  Xin Ran; Shuzhi Zhou; Kailan Cao; Peng He
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-25       Impact factor: 3.105

6.  The Efficacy of Programmed Intermittent Epidural Bolus for Postoperative Analgesia after Open Gynecological Surgery: A Randomized Double-Blinded Study.

Authors:  Shiho Satomi; Nami Kakuta; Chiaki Murakami; Yoko Sakai; Katsuya Tanaka; Yasuo M Tsutsumi
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

7.  Labor Epidural Analgesia: Comparison of Two Different Intermittent Bolus Regimes.

Authors:  Nitu Puthenveettil; Anish Mohan; Sunil Rajan; Jerry Paul; Lakshmi Kumar
Journal:  Anesth Essays Res       Date:  2018 Oct-Dec

8.  Optimum interval time of programmed intermittent epidural bolus of ropivacaine 0.08% with sufentanyl 0.3 μg/mL for labor analgesia: a biased-coin up-and-down sequential allocation trial.

Authors:  Shuang-Qiong Zhou; Jing Wang; Wei-Jia Du; Yu-Jie Song; Zhen-Dong Xu; Zhi-Qiang Liu
Journal:  Chin Med J (Engl)       Date:  2020-03-05       Impact factor: 2.628

9.  Programmed intermittent epidural bolus in parturients: A meta-analysis of randomized controlled trials.

Authors:  Xian-Xue Wang; Xiao-Lan Zhang; Zhao-Xia Zhang; Zi-Qin Xin; Hua-Jing Guo; Hai-Yan Liu; Jing Xiao; Yun-Lin Zhang; Shu-Zhen Yuan
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.